- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Infliximab (biosimilar) – November 2016
Infliximab (biosimilar) : Powder for I.V. infusion 100 mg; Renflexis®
Last updated
3 March 2017